Compare Bio Protocol (BIO) vs COTI (COTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs COTI — how do they compare? Bio Protocol trades at Rp513.53 (market cap Rp1,15T, Rp256,3M 24h volume), while COTI trades at Rp140.72 (market cap Rp410,53M, Rp39,29M 24h volume). The key difference: Bio Protocol is far larger — about 2801.3× COTI's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 2,9B / 4,9B COTI (60%) for COTI. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and COTI for 120 Days on average.
| BIO | COTI | |
|---|---|---|
Market Cap | Rp1,15T | Rp410,53M |
Volume (24h) | Rp256,3M | Rp39,29M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 2,9B / 4,9B COTI (60%) |
Typical Hold Time | 16 Days | 120 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
COTI is currently trading at Rp140.54 with a bearish technical outlook, showing strong selling pressure across moving averages and neutral oscillators. The token trades near key support levels with 60% of its 4.9M max supply in circulation. Recent technical indicators show RSI levels in neutral territory while ADX signals selling momentum. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with technical weakness dominating. Key opportunities include potential bounce from support levels, while risks include continued bearish momentum and limited fundamental catalysts. Investors should monitor for any protocol updates or exchange listing developments that could impact sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About COTI
COTI markets itself as the first enterprise-grade fintech platform that empowers organizations to build their own payment solutions as well as digitize any currency to save time as well as money. It is one of the world’s first blockchain protocols that is optimized for decentralized payments and designed for use by merchants, governments, payment DApps, and stablecoin issuers.
Read more on COTI →
